Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-08-26 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIROFLAY (78220), Yvelines
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE PRINCIPALE : revenue, balance sheet and financial ratios
SELARL PHARMACIE PRINCIPALE is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIROFLAY (78220),
this company of category PME
shows in 2017 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE PRINCIPALE (SIREN 794632448)
Indicator
2024
2024
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 796 694 €
Net income
-19 795 €
-58 069 €
107 307 €
38 846 €
99 048 €
72 697 €
57 461 €
92 235 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
187 500 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
5.1%
Revenue and income statement
In 2024, SELARL PHARMACIE PRINCIPALE records a net loss of 20 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-19 795 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
25.514%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
78.495%
Solvency indicators evolution SELARL PHARMACIE PRINCIPALE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
2024
Debt ratio
401.992
300.637
211.211
140.782
132.374
94.128
81.792
25.514
Financial autonomy
17.157
21.546
27.462
33.701
36.577
43.112
46.378
78.495
Repayment capacity
8.567
None
None
None
None
None
None
None
Cash flow / Revenue
7.486%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
25.512024
2022
2024
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-24 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE PRINCIPALE (25.51) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
78.5%2024
2022
2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+37 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE PRINCIPALE (78.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 6733.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
6733.178
Liquidity indicators evolution SELARL PHARMACIE PRINCIPALE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2024
2024
Liquidity ratio
130.738
123.086
101.068
87.939
115.442
120.986
96.601
6733.178
Interest coverage
11.583
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
6733.182024
2022
2024
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent+54 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE PRINCIPALE (6733.18) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE PRINCIPALE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
2024
Operating WCR
194 528 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
40
0
0
0
0
0
0
0
Customer payment term (days)
8
0
0
0
0
0
0
0
Supplier payment term (days)
44
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE PRINCIPALE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE PRINCIPALE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE PRINCIPALE
What is the revenue of SELARL PHARMACIE PRINCIPALE ?
The revenue of SELARL PHARMACIE PRINCIPALE in 2017 is 1.8 M€.
Is SELARL PHARMACIE PRINCIPALE profitable?
SELARL PHARMACIE PRINCIPALE recorded a net loss in 2024.
Where is the headquarters of SELARL PHARMACIE PRINCIPALE ?
The headquarters of SELARL PHARMACIE PRINCIPALE is located in VIROFLAY (78220), in the department Yvelines.
Where to find the tax return of SELARL PHARMACIE PRINCIPALE ?
The tax return of SELARL PHARMACIE PRINCIPALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE PRINCIPALE operate?
SELARL PHARMACIE PRINCIPALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart